VanEck Biotech ETF
Price through Oct 5 · Flows through Oct 2. Figures use the latest available records, not a live quote. Fund details retrieved Oct 5. Holdings snapshot retrieved Oct 5.
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
SOURCE: MARKET TAPE & DAILY CREATION/REDEMPTION RECORDS · 1Y SHOWN · NET −$21M OVER THIS RANGE
Money is leaving — −$5M in net outflows over the past month, about 1.0% of the fund's asset base, while the price has returned +27.1% so far this year. At 0.35% a year it is not the cheapest way in — AVIE has a reported fee of 0.25%.
COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH
CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS THE CHANGE IN THE LATEST AVAILABLE SNAPSHOT · TOP 40 POSITIONS
| # | Holding | Weight | Price | Day | 52-wk | |
|---|---|---|---|---|---|---|
| 1 | AMGNAMGEN | 15.53% | $402.98 | -0.0% | ||
| 2 | GILDGILEAD SCIENCES | 13.18% | $144.63 | -0.1% | ||
| 3 | VRTXVERTEX PHARMACEUTICALS | 8.17% | $503.50 | -0.2% | ||
| 4 | MRNAMODERNA | 6.16% | $203.21 | +6.9% | ||
| 5 | REGNREGENERON PHARMACEUTICALS | 6.49% | $726.47 | -1.2% | ||
| 6 | NTRANATERA | 5.46% | $425.64 | +3.7% | ||
| 7 | IQVIQVIA HOLDINGS | 4.42% | $266.09 | +3.1% | ||
| 8 | ARGXARGENX SE | 4.53% | $912.87 | -0.7% | ||
| 9 | ILMNILLUMINA | 4.15% | $293.69 | +7.6% | ||
| 10 | RVMDREVOLUTION MEDICINES | 4.37% | $207.68 | +0.5% | ||
| 11 | GHGUARDANT HEALTH | 3.09% | $187.22 | +5.3% | ||
| 12 | ONCBeiGene | 2.78% | $361.65 | +1.0% | ||
| 13 | BIIBBIOGEN | 2.74% | $223.59 | +1.7% | ||
| 14 | ALNYALNYLAM PHARMACEUTICALS | 2.48% | $219.89 | +0.1% | ||
| 15 | UTHRUNITED THERAPEUTICS | 2.31% | $536.40 | -1.0% |
The full book, free with one sign-in.
Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus CSV export, watchlists, and flow alerts — unlock across the network.
Sign in to see all 26| 1 week | -2.1% |
| 1 month | -0.2% |
| 3 months | +13.8% |
| 6 months | +28.1% |
| YTD | +27.1% |
| 1 year | — |
| 3 years | — |
PRICE RETURN, DISTRIBUTIONS NOT REINVESTED
| 1 week | +$2M |
| 1 month | −$5M |
| 3 months | +$15M |
| YTD | +$7M |
| 1 year | −$21M |
CREATION/REDEMPTION DOLLARS, DAILY RECORDS
The top holding is 15.5% of the book; the top ten carry 72%. Spread across 25+ names, it behaves like roughly 14 equally-weighted positions.
VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK
| Most-traded holdings, options premium | Bullish | Bearish |
|---|---|---|
| MRNA MODERNA | $49M | $46M |
| TEM TEMPUS AI INC | $6M | $3M |
| NTRA NATERA | $2M | $3M |
| ILMN ILLUMINA | $2M | $2M |
| AMGN AMGEN | $2M | $2M |
TODAY’S OPTIONS PREMIUM IN THE FUND’S UNDERLYING NAMES
Due diligence cuts both ways. These funds sit on the same shelf and beat BBH on at least one dimension that matters — the fee, the asset base, or where the money is going.
| Fund | Fee | Assets | Flow, 1M | The case | |
|---|---|---|---|---|---|
| SPDW State Street SPDR Portfolio Developed World ex-US ETF | 0.03% | $41.5B | +$286M | -32bp on fee · 87× the assets · +$286M in over the month | Head-to-head |
| SPMD State Street SPDR Portfolio S&P 400 Mid Cap ETF | 0.03% | $18.2B | +$199M | -32bp on fee · 38× the assets · +$199M in over the month | Head-to-head |
| IDEV iShares Core MSCI International Developed Markets ETF | 0.04% | $32.9B | +$497M | -31bp on fee · 69× the assets · +$497M in over the month | Head-to-head |
| IGSB iShares 1-5 Year Investment Grade Corporate Bond ETF | 0.04% | $23.7B | +$575M | -31bp on fee · 50× the assets · +$575M in over the month | Head-to-head |
| IGIB iShares 5-10 Year Investment Grade Corporate Bond ETF | 0.04% | $18.6B | +$412M | -31bp on fee · 39× the assets · +$412M in over the month | Head-to-head |